The Knight Cancer Institute at Portland-based Oregon Health & Science University has appointed Joel Helmke as CEO of the Knight Cancer Group.
The Knight Cancer Group — established through a $2 billion donation from Phil and Penny Knight — will govern the Knight Cancer Institute’s new care model and manage OHSU’s cancer services.
Mr. Helmke will step into the role in mid-March after serving as COO of Philadelphia-based Fox Chase Cancer Center since 2021, according to a Jan. 26 news release from the university.
He has previously served as senior vice president of clinical operations at Duarte, Calif.-based City of Hope and as system vice president for Marietta, Ga.-based WellStar Cancer Network. He spent 14 years of his career at Houston-based University of Texas MD Anderson Cancer Center, including as executive director and division administrator of internal medicine.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
